Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 97 Pages
Report ld: 3489637
Request Sample
Customized Report
Insulin Injection Consumables Market Size(US$)

CAGR 2025-2031
8%
Market Size,2031
USD 4,293
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Insulin Injection Consumables was valued at US$ 2523 million in the year 2024 and is projected to reach a revised size of US$ 4293 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
The insulin injection consumables market is witnessing significant growth as a crucial component of diabetes management. These consumables include insulin syringes, pens, and needles used to administer insulin to individuals with diabetes. The market"s expansion is driven by the increasing prevalence of diabetes and the need for effective insulin delivery methods. Insulin injection consumables offer convenience, accuracy, and reduced pain during administration. As diabetes care becomes more personalized and patient-centric, the demand for reliable and user-friendly injection devices is rising. With advancements in design and technology, the insulin injection consumables market is poised to continue growing, contributing to improved quality of life for individuals managing diabetes.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Insulin Injection Consumables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Injection Consumables.
The Insulin Injection Consumables market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Injection Consumables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Injection Consumables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed Holding
Owen Mumford
HTL-Strefa
Beipu
Kangdelai
Ulticare
Allison Medical
Segment by Type
Insulin Injection Pen
Insulin Injection Needle
Segment by Application
Hospital
Home
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Injection Consumables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Injection Consumables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Insulin Injection Consumables Market Overview
1.1 Product Definition
1.2 Insulin Injection Consumables by Type
1.2.1 Global Insulin Injection Consumables Market Value Comparison by Type (2024 VS 2031)
1.2.2 Insulin Injection Pen
1.2.3 Insulin Injection Needle
1.3 Insulin Injection Consumables by Application
1.3.1 Global Insulin Injection Consumables Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Home
1.3.4 Others
1.4 Global Insulin Injection Consumables Market Size Estimates and Forecasts
1.4.1 Global Insulin Injection Consumables Revenue 2020-2031
1.4.2 Global Insulin Injection Consumables Sales 2020-2031
1.4.3 Global Insulin Injection Consumables Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Injection Consumables Market Competition by Manufacturers
2.1 Global Insulin Injection Consumables Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Injection Consumables Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Injection Consumables Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Injection Consumables, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Injection Consumables, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Injection Consumables, Product Type & Application
2.7 Global Key Manufacturers of Insulin Injection Consumables, Date of Enter into This Industry
2.8 Global Insulin Injection Consumables Market Competitive Situation and Trends
2.8.1 Global Insulin Injection Consumables Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Injection Consumables Players Market Share by Revenue
2.8.3 Global Insulin Injection Consumables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Injection Consumables Market Scenario by Region
3.1 Global Insulin Injection Consumables Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Injection Consumables Sales by Region: 2020-2031
3.2.1 Global Insulin Injection Consumables Sales by Region: 2020-2025
3.2.2 Global Insulin Injection Consumables Sales by Region: 2026-2031
3.3 Global Insulin Injection Consumables Revenue by Region: 2020-2031
3.3.1 Global Insulin Injection Consumables Revenue by Region: 2020-2025
3.3.2 Global Insulin Injection Consumables Revenue by Region: 2026-2031
3.4 North America Insulin Injection Consumables Market Facts & Figures by Country
3.4.1 North America Insulin Injection Consumables Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Injection Consumables Sales by Country (2020-2031)
3.4.3 North America Insulin Injection Consumables Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Injection Consumables Market Facts & Figures by Country
3.5.1 Europe Insulin Injection Consumables Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Injection Consumables Sales by Country (2020-2031)
3.5.3 Europe Insulin Injection Consumables Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Injection Consumables Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Injection Consumables Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Injection Consumables Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Injection Consumables Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insulin Injection Consumables Market Facts & Figures by Country
3.7.1 Latin America Insulin Injection Consumables Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Injection Consumables Sales by Country (2020-2031)
3.7.3 Latin America Insulin Injection Consumables Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Injection Consumables Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Injection Consumables Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Injection Consumables Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Injection Consumables Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Injection Consumables Sales by Type (2020-2031)
4.1.1 Global Insulin Injection Consumables Sales by Type (2020-2025)
4.1.2 Global Insulin Injection Consumables Sales by Type (2026-2031)
4.1.3 Global Insulin Injection Consumables Sales Market Share by Type (2020-2031)
4.2 Global Insulin Injection Consumables Revenue by Type (2020-2031)
4.2.1 Global Insulin Injection Consumables Revenue by Type (2020-2025)
4.2.2 Global Insulin Injection Consumables Revenue by Type (2026-2031)
4.2.3 Global Insulin Injection Consumables Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Injection Consumables Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Injection Consumables Sales by Application (2020-2031)
5.1.1 Global Insulin Injection Consumables Sales by Application (2020-2025)
5.1.2 Global Insulin Injection Consumables Sales by Application (2026-2031)
5.1.3 Global Insulin Injection Consumables Sales Market Share by Application (2020-2031)
5.2 Global Insulin Injection Consumables Revenue by Application (2020-2031)
5.2.1 Global Insulin Injection Consumables Revenue by Application (2020-2025)
5.2.2 Global Insulin Injection Consumables Revenue by Application (2026-2031)
5.2.3 Global Insulin Injection Consumables Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Injection Consumables Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Insulin Injection Consumables Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Company Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novo Nordisk Insulin Injection Consumables Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Artsana
6.3.1 Artsana Company Information
6.3.2 Artsana Description and Business Overview
6.3.3 Artsana Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Artsana Insulin Injection Consumables Product Portfolio
6.3.5 Artsana Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Company Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B. Braun Insulin Injection Consumables Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Company Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Terumo Insulin Injection Consumables Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Ypsomed Holding
6.6.1 Ypsomed Holding Company Information
6.6.2 Ypsomed Holding Description and Business Overview
6.6.3 Ypsomed Holding Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ypsomed Holding Insulin Injection Consumables Product Portfolio
6.6.5 Ypsomed Holding Recent Developments/Updates
6.7 Owen Mumford
6.7.1 Owen Mumford Company Information
6.7.2 Owen Mumford Description and Business Overview
6.7.3 Owen Mumford Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Owen Mumford Insulin Injection Consumables Product Portfolio
6.7.5 Owen Mumford Recent Developments/Updates
6.8 HTL-Strefa
6.8.1 HTL-Strefa Company Information
6.8.2 HTL-Strefa Description and Business Overview
6.8.3 HTL-Strefa Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HTL-Strefa Insulin Injection Consumables Product Portfolio
6.8.5 HTL-Strefa Recent Developments/Updates
6.9 Beipu
6.9.1 Beipu Company Information
6.9.2 Beipu Description and Business Overview
6.9.3 Beipu Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Beipu Insulin Injection Consumables Product Portfolio
6.9.5 Beipu Recent Developments/Updates
6.10 Kangdelai
6.10.1 Kangdelai Company Information
6.10.2 Kangdelai Description and Business Overview
6.10.3 Kangdelai Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kangdelai Insulin Injection Consumables Product Portfolio
6.10.5 Kangdelai Recent Developments/Updates
6.11 Ulticare
6.11.1 Ulticare Company Information
6.11.2 Ulticare Description and Business Overview
6.11.3 Ulticare Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ulticare Insulin Injection Consumables Product Portfolio
6.11.5 Ulticare Recent Developments/Updates
6.12 Allison Medical
6.12.1 Allison Medical Company Information
6.12.2 Allison Medical Description and Business Overview
6.12.3 Allison Medical Insulin Injection Consumables Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Allison Medical Insulin Injection Consumables Product Portfolio
6.12.5 Allison Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Injection Consumables Industry Chain Analysis
7.2 Insulin Injection Consumables Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Injection Consumables Production Mode & Process Analysis
7.4 Insulin Injection Consumables Sales and Marketing
7.4.1 Insulin Injection Consumables Sales Channels
7.4.2 Insulin Injection Consumables Distributors
7.5 Insulin Injection Consumables Customer Analysis
8 Insulin Injection Consumables Market Dynamics
8.1 Insulin Injection Consumables Industry Trends
8.2 Insulin Injection Consumables Market Drivers
8.3 Insulin Injection Consumables Market Challenges
8.4 Insulin Injection Consumables Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Insulin Injection Consumables was estimated to be worth US$ 2705 million in 2025 and is projected to reach US$ 4602 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
The global Insulin Injection Consumables market was valued at US$ 2705 million in 2025 and is anticipated to reach US$ 4602 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 120
USD 2900.00
(Single User License)
The global Insulin Injection Consumables market size was US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 95
USD 4250.00
(Single User License)
The global Insulin Injection Consumables market is projected to grow from US$ 2523 million in 2024 to US$ 4293 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 170
USD 4900.00
(Single User License)
The global market for Insulin Injection Consumables was estimated to be worth US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 118
USD 3950.00
(Single User License)
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published Date: 2024-04-15
Pages: 108
USD 4900.00
(Single User License)
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published Date: 2024-01-17
Pages: 88
USD 2900.00
(Single User License)
The global market for Insulin Injection Consumables was estimated to be worth US$ 2705 million in 2025 and is projected to reach US$ 4602 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 142
The global Insulin Injection Consumables market was valued at US$ 2705 million in 2025 and is anticipated to reach US$ 4602 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 120
The global Insulin Injection Consumables market size was US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 95
The global Insulin Injection Consumables market is projected to grow from US$ 2523 million in 2024 to US$ 4293 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 170
The global market for Insulin Injection Consumables was estimated to be worth US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 118
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published: 2024-04-15
Pages: 108
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published: 2024-01-17
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now